| Catalog No. | 
			TD-HF802026 | 
		
		
			| Species reactivity | 
			Human | 
		
		
			| Applications | 
			Research Grade Biosimilar | 
		
		
			| Host species | 
			Humanized | 
		
		
			| Isotype | 
			IgG1-kappa (DVD-Ig) | 
		
		
			| Expression system | 
			Mammalian Cells | 
		
		
			| Species | 
			Human | 
		
		
			| Clonality | 
			Monoclonal | 
		
		
			| Target | 
			IL1F1, Interleukin-1 alpha, IL1A, Hematopoietin-1, IL-1 alpha, Interleukin-1 beta, IL1B, Catabolin, IL1F2, IL-1 beta | 
		
		
			| Endotoxin level | 
			Please contact with the lab for this information. | 
		
		
			| Purity | 
			>95% as determined by SDS-PAGE. | 
		
		
			| Purification | 
			Protein A/G purified from cell culture supernatant. | 
		
		
			| Accession | 
			P01583 & P01584 | 
		
		
			| Form | 
			Liquid | 
		
		
			| Storage buffer | 
			0.01M PBS, pH 7.4. | 
		
		
			| Stability and Storage | 
			Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. | 
		
		
			| Alternate Names | 
			Bispecific, ABT-981, CAS: 1791411-57-8 | 
		
		
			| Background | 
			Lutikizumab (ABT-981) is an anti-IL-1α and IL-1β dual variable domain immunoglobulin. Lutikizumab binds and inhibits IL-1α and IL-1β. Lutikizumab can be used for the research of osteoarthritis. | 
		
		
			| Note | 
			For research use only. Not suitable for clinical or therapeutic use. |